No Data
No Data
Investors in Theravance Biopharma (NASDAQ:TBPH) Have Unfortunately Lost 52% Over the Last Five Years
Mama's Creations, GameStop And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
Sidoti Events, LLC's Virtual June Small-Cap Conference
Analysts Offer Insights on Healthcare Companies: Corcept Therapeutics (CORT), Theravance Biopharma (TBPH) and Merus (MRUS)
TD Cowen Maintains Theravance Biopharma(TBPH.US) With Hold Rating, Maintains Target Price $10
TD Cowen analyst Marc Frahm maintains $Theravance Biopharma(TBPH.US)$ with a hold rating, and maintains the target price at $10.According to TipRanks data, the analyst has a success rate of 47.0% and
Theravance Biopharma (TBPH) Receives a Hold From TD Cowen